{
  "pmcid": "9577542",
  "sha256": "130f94d86788c7b3da59409201a7d14af0ac72170771bc147f6d326503b78fae",
  "timestamp_utc": "2025-11-10T00:12:57.222093+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.204047871534616,
    "reading_ease": 44.12984396303594,
    "word_count": 287
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Timing of Surgery Post-Chemoradiotherapy in Locally Advanced Rectal Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients with LARC within 12 cm of the anal verge (T3–T4 or N+ disease) were randomised using an adaptive biased coin technique"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with LARC within 12 cm of the anal verge (T3–T4 or N+ disease)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "undergoing total mesorectal excision (TME) after a waiting interval of 8 weeks or less (classic interval; CI) versus more than 8 weeks (long interval; LI) following preoperative CRT"
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial assessed disease recurrence and survival rates between patients undergoing total mesorectal excision (TME) after a waiting interval of 8 weeks or less (classic interval; CI) versus more than 8 weeks (long interval; LI) following preoperative CRT."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pathological complete response (pCR) rate, measured at the time of surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Patients with LARC within 12 cm of the anal verge (T3–T4 or N+ disease) were randomised using an adaptive biased coin technique to undergo TME within or after 8 weeks post-CRT. Randomisation was performed by two surgeons, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Pathologists assessing outcomes were blinded to group assignments."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between January 2006 and January 2017, 350 patients were randomised (175 to each group)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of these, 322 were analysed (CI, 159; LI, 163) using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The cumulative incidence of distant metastasis at 5 years was 30.8% in the CI group and 18.6% in the LI group (sub-HR = 1.78; 95% CI 1.14 to 2.78, P = 0.010)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not specified."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03287843."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}